On the basis of our 2011 microbiological monitoring tests, we report here the current microbiological status of mice and rats housed in experimental facilities in Japan. We tested more than 14,000 mice, 6,000 serum samples, 500 fecal or cecal samples, and 200 lung samples from 3,549 mouse facilities within Japanese universities and institutes (U/I), pharmaceutical companies and contract research organizations (P/C). We also tested more than 1,500 rats, 1,600 serum samples, and 20 fecal or cecal samples from 772 U/I and P/C rat facilities. Bacterial cultures, serology, microscopy, PCR, and DNA analysis using DNA chips were performed. Staphylococcus aureus (18.8% in mouse facilities, 58.6% in rat facilities) was the most prevalent agent in both the mouse and rat facilities. The next most prevalent agents in the mouse facilities were murine norovirus (11.97%), intestinal protozoa (0.05-8.49%, from various species), Pasteurella pneumotropica (5.32%), and Helicobacter hepaticus (3.17%), while intestinal protozoa (0.74-6.84% from various species), Syphacia muris (6.20%), Pseudomonas aeruginosa (3.61%), and Pasteurella pneumotropica (3.05%) were the subsequent most prevalent agents in the rat facilities. These results suggest that the currently prevalent microbes in laboratory mice and rats in Japan are mainly opportunistic pathogens, intestinal protozoa, and microbes with low pathogenicity.
Introduction
currently, laboratory mice and rats are widely used in animal experiments across many fields of studies. To obtain highly reproducible and reliable experimental results, use of animals that are guaranteed to possess microbiological and genetic quality is necessary. Microbiological monitoring, defined as the practice of scheduled, repetitive testing of an animal colony for evidence of selected microbiological infections [11] , is the only way to guarantee the microbiological quality of laboratory animals.
The microbiological status of mice and rats in animal facilities is known to change over time. The number of microbes in test items is still increasing, as shown by the discovery of newly detected pathogens, such as Helicobacter hepaticus [2] and murine norovirus (MNV) [13] . Knowing the current microbiological status in laboratory mice and rats is indispensable from the standpoint of selection of microbiological monitoring items in each animal facility. This study describes the current microbiological status of mice and rats in experimental facilities in Japan. It is based on our results of microbiological monitoring test results collected in 2011 from domestic experimental facilities in universities, national or private institutes, pharmaceutical companies, and contract research organizations.
Materials and Methods

Animals and samples
In 2011, we tested 12,885 mice, 2,699 serum samples, 311 fecal or cecal samples, and 1 lung sample from 2,534 mouse facilities in universities and institutes (U/I) within Japan, as well as 1,656 mice, 3,611 serum samples, 215 fecal or cecal samples, and 248 lung samples from 1,015 mouse facilities in pharmaceutical companies and contract research organizations (P/C) within Japan. We also tested 745 rats, 461 serum samples, and 6 fecal or cecal samples from 335 U/I rat facilities, as well as 768 rats, 1,173 serum samples, and 17 fecal or cecal samples from 437 P/C facilities. Animals and samples from commercial breeders or other contract testing laboratories were not included in this study.
Animals were euthanized by exsanguination from the axillary artery and vein under isoflurane anesthesia. Necropsy was then performed, and samples for each test were collected. The protocol for collecting samples for microbiological monitoring was approved by the institutional animal care and use committee based on the Regulations for Animal Experimentation of the Central Institute for Experimental Animals. The regulations were established in compliance with the law for the humane treatment and management of animals.
Selection of test items
A total of 36 microbiological monitoring test items for mice and 32 microbiological test items for rats were used in this study (Tables 1 and 2 ). Microbes were categorized in the following manner for their pathogenicity [12] : Category A, zoonotic and human pathogens carried by mice or rats; category B, indigenous mouse or rat pathogens that can cause symptomatic disease and occasional death of mice or rats; Category C, microbes that usually cause asymptomatic infections of mice or rats accompanied with alterations in physiological functions; category d, microbes that can cause opportunistic infections; and Category E, microbes that are usually nonpathogenic but indicate the hygiene status of the rearing environment.
Test methods
Culture tests: Culture tests were performed for all bacteria except for Helicobacter hepaticus, Helicobacter bilis, cilia-associated respiratory bacillus (CAR bacillus), and Clostridium piliforme. Conjunctival and tracheal swabs were streaked directly to horse blood agar (Eiken Chemical Co., Ltd., Tokyo, Japan) and/or Chanock's PPLO agar [9] supplemented with horse serum (Life Technologies, Carlsbad, CA, USA) and yeast extract (made in-house) for respiratory pathogens. Cecal contents were streaked onto selective agars such as DHL agar (Eiken Chemical), NAC agar (Eiken Chemical), and X-SA agar (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) to evaluate the presence of intestinal pathogens. Colonies were recovered from the agar plates after incubations at 37°C for 24 h (DHL agar and X-SA agar), 48 h (blood agar and NAC agar), or 7 d (PPLO agar). The colonies suspected to be the agent in bacterial items were passaged and established as a pure culture on horse blood agar (Eiken Chemical) or heart infusion agar (Eiken Chemical). The bacterial isolates were then identified using the following tests: gram staining, catalase test, oxidase test, and biochemical tests using commercially available kits, such as the Api series (Sysmex bioMérieux Co., Ltd., Tokyo, Japan) and ID test series (Nissui Pharmaceutical). For the identification of Staphylococcus aureus and Mycoplasma pulmonis, previously reported PCR tests were utilized without the biochemical tests [6, 8] . For isolation of dermatophytes, a small sample of hair was obtained from the shoulder and back of the animals and inoculated onto potato dextrose agar (Eiken Chemical). After incubation at 25°C for 14 d, the agar plates were assessed for the existence of any colonies. When suspected colonies appeared on the agar, they were identified on the basis of their morphology [17] .
Serology: Serological tests were performed for M. pulmonis, C. piliforme, car bacillus and all viral items except for MNV. Test sera were diluted 1:40 for ELISA or 1:10 for indirect immunofluorescence assays (IFAs) and agglutination tests. As a secondary antibody for these tests, protein A and anti-rat IgG were used for mouse samples and rat samples in ELISA, respectively. FITClabeled anti-mouse IgG and FITC-labeled anti-rat IgG were used as secondary antibodies in IFA for samples derived from each respective species.
In our center, most serological tests were performed using ELISA as the primary screening test and IFA as the confirmation test. For the mouse parvovirus (MPV) test, a recombinant antigen (see below) was used for ELISA, and mouse minute virus antigen was used in IFA to detect cross-reactive antibodies [14] . Lymphocytic choriomeningitis virus (LCMV), Kilham rat virus, and H-1 virus were tested by using IFA alone. Some serological tests, such as those for Corynebacterium kutscheri and Salmonella typhimurium, were performed using agglutination tests [12] . All the ELISA plates were prepared in our center, except for 5 ELISA tests (mouse hepatitis virus [MHV] , M. pulmonis, hantavirus, sendai virus, and C. piliforme). Commercially available ELISA kits (MO-NILISA tm , Wakamoto Pharmaceutical Co., Ltd., Tokyo, Japan) were used for these 5 tests. The recombinant MPV antigen [14] used in the MPV ELISA test was provided by Tsukuba University. IFA antigen slides were prepared by our center, except for the IFA tests for LCMV and hantavirus, for which the antigen slides were provided by Nagasaki university and Hokkaido university, respectively. The serological test procedures were performed by a previously described method [4] . All the strain names of bacteria and viruses used as serological antigens are listed in Table 3 . Microscopy: Microscopic analyses were performed for ectoparasites, intestinal protozoa, pinworms, and Pneumocystis spp. Cellophane tape was impressed upon the buttock and/or backside as well as the perianal area for microscopic examination of ectoparasites and for examining the ova of Syphacia spp., respectively. A rectum sample was floated in a petri dish with saline for determining the presence of Aspiculuris tetraptera. When the existence of pinworms was observed macroscopically in a petri dish, the pinworms were identified on the basis of their morphology by using a microscope. Wet mount specimens of duodenal or cecal contents were mixed with a drop of saline and examined microscopically for determining the intestinal protozoa. The species determination for intestinal protozoa was performed by morphological analysis as well as on the basis of their characteristic movement patterns. the lung sample homogenate were microscopically examined with toluidine blue O staining for Pneumocystis spp. [3] . When the existence of Pneumocystis-like cysts were observed, a previously reported PCR test for Pneumocystis [10] was performed on the aliquoted samples to confirm the presence of this fungi.
Molecular tests: PCR tests for H. hepaticus and H. bilis as well as RT-PCR tests for MNV were performed using previously reported primers and procedures [4, 5] . Fecal or cecal samples were obtained from animals and stored at −80°C until the tests were performed. As confirmation tests for all PCR positive samples of H. hepaticus and H. bilis, dNa analysis using dNa chips was performed. The DNA chip-analyzing device (Genelyzer tm , Toshiba Corporation, Tokyo, Japan), analyzing kits (Monigene Helico tm , Toshiba), and DNA chip were used according to manufacturer's instructions. All the PCR products in MNV RT-PCR tests were directly sequenced and compared with the data available in a public database (GenBank) for verification.
Data analysis
In this study, 1 request was regarded as 1 facility regardless of the sample number. The facilities were categorized as U/I or PC using information provided by the client, and the results were compiled for each U/I and PC.
Results
The survey results for the mouse and rat facilities are summarized in Tables 1, and 2 , respectively.
Bacteria
Staphylococcus aureus was the most prevalent microbial agent in mice and rats in both U/I and P/C facilities. The positive infection rate percentage of Staphylococcus aures was 18.8% (U/I, 21.45%, and P/C, 10.87%) in mouse facilities and 58.62% (U/I, 68.42%, and P/C, 40.0%) in rat facilities. In the mouse facilities, Pasteurella pneumotropica (6.14%), H. hepaticus (4.33%), Pseudomonas aeruginosa (2.75%), H. bilis (0.25%), and M. pulmonis (serology, 0.1%, and culture tests, 0.05%) were the next most prevalent microbes in the U/I facilities. Although no other bacterial agents were detected in mice in the P/C facilities by performing culture tests, seropositive cases of M. pulmonis (0.46%) were found.
In rat facilities, Pseudomonas aeruginosa (3.61%), Pasteurella pneumotropica (3.05%), CAR bacillus (1.49%), C. piliforme (0.97%), and M. pulmonis (serology, 0.57%) followed Staphylococcus aureus as the next most prevalent micorbes. Of these agents, Pseudomonas aeruginosa, C. piliforme, and, M. pulmonis were detected or seropositive in 5.88, 1.7, and 1.08% in U/I rat facilities, respectively. Seropositive cases of CAR bacillus were found only in the P/C rat facilities (2.22%).
Virus
In the mouse facilities, MNV was the most prevalent viral agent. The positive infection rate percentage of MNV was 11.97% (U/I, 9.38%, and P/C, 23.81%). MHV was the second most prevalent viral agent. The positive infection rate percentage of MHV was 0.68% (U/I, 0.5%, and P/C, 1.37%). No positive cases for any of the other viral agents were detected in mice from both U/I and P/C facilities. In the rat facilities, no seropositive cases were detected in both U/I and P/C facilities.
Other agents
In P/C mouse facilities, no parasitic agents (i.e., intestinal protozoa, pinworms, or ectoparasites) were detected. In U/I mouse facilities, the most prevalent parasitic agent was the Amoeba (9.75%). Octomitus intestinalis (7.96%), Tritrichomonas muris (5.68%), Chilomastix bettencourti (3.41%), Aspiculuris tetraptera (3.26%), Syphacia obvelata (1.51%), and Spironucleus muris (0.05%) were the next most prevalent parasitic agents in mice. Pneumocystis murina was detected in mice in both U/I and P/C facilities (U/I, 0.48%, and P/C, 1.41%). Similar to the mice in P/C facilities, no parasitic agents were detected in the rats housed in P/C facilities. The most prevalent parasitic agent in rats housed in U/I facilities was the Amoeba (10.17%). Syphacia muris (9.29%), Tritrichomonas muris (4.52%), Octomitus intestinalis (3.39%), Chilomastix bettencourti (1.13%), Spironucleus muris (1.09%), and Aspiculuris tetraptera (0.56%) followed as the next most prevalent parasitic agents in rats.
In mouse and rat necropsies, gross lesions in major organs (38 cases of lesions in the liver, 18 cases of lesions in lungs, 9 cases of lesions in skin, 6 cases of lesions in the spleen and lymph nodes, 4 cases of lesions in the kidney, 2 cases of lesions in mammalian glands, and 1 case of an eye lesion) were observed in 78 mice and rats. Among them, Staphylococcus aureus was isolated from 2 cases of subcutaneous abscesses in C57BL/6 mice, Pasteurella pneumotropica was isolated from 1 case of lung consolidation in a genetically modified mouse, and Pneumocystis murina was detected in 2 cases of lung consolidations in genetically modified mice.
Discussion
in this study, we showed the current microbiological status of mice and rats housed in experimental facilities in Japan based on data collected from our 2011 microbiological monitoring test results. In our center, it was difficult to verify whether the samples originated from either an SPF facility or non-SPF facility. Therefore, the results were categorized and analyzed as originating from U/I or P/C. in our study, we aimed to understand the current trends of the prevalent microbes in monitoring selected items in mice and rats from experimental facilities, and also aimed to provide practical information to workers in these experimental facilities in return. Therefore, the data was categorized into U/I and PC facilities and macroscopically analyzed on the basis of facility number in this study. A sample number-based analysis of our data will present smaller positive rates than those of facility number-based analysis for each microbe. In the case of some microbes found to be positive in the mice and rats, the numbers of facilities tested for microbes such as Pseudomonas aeruginosa, Staphylococcus aureus, Pneumocystis murina, Helicobacter hepaticus, Helicobacter bilis, and MNV for mice and Pseudomonas aeruginosa, Staphylococcus aureus, car bacillus, and Pneumocysitis carinii for rats were at least 10-fold smaller than for other tested microbes. Although testing of a larger number of facilities should reveal values closer to the actual figures for the prevalence of the microbes mentioned above, the discussion below is based on the premise that our data represent the indicated difference in tested number among each microbe.
We found that mice housed in the U/I facilities were positive for 17 items, whereas the mice in P/C facilities were positive for 5 items. A similar trend (U/I, 12 items, and P/C, 3 items) was observed for the rat facilities. Thus, the microbiological quality of mice and rats housed in P/C facilities is higher than that of the mice and rats housed in U/I facilities.
in the present study, Staphylococcus aureus was found to be the most prevalent bacterial agent in both the mouse and rat facilities. This bacterium is regarded as an opportunistic pathogen for immunocompetent animals and is often not included as a routine test item for immunocompetent mice and rats by some of the commercial breeders in Japan. In our center, Staphylococcus aureus was considered as an optional item for immunocompetent animals. This background regarding testing for this opportunistic pathogen may be a cause of the high prevalence of Staphylococcus aureus in mice and rats in Japan.
The next most prevalent bacterial agents found in mouse facilities were Pasteurella pneumotropica and H. hepaticus, with Pseudomonas aeruginosa following closely behinded. In rat facilities, Pseudomonas aeruginosa and Pasteurella pneumotropica were the most prevalent bacterial agents following Staphylococcus aureus. Except for H. hepaticus, these bacteria are categorized as Category D pathogens (opportunistic pathogens) in our center.
collectively, these results suggest that the most prevalent bacterial agents in mouse and rat facilities in Japan are opportunistic pathogens.
Our group previously reported the prevalence of the Helicobacter species in mouse colonies in Japan in 2000 [7] , and H. hepaticus and H. bilis were detected in 25.5 and 2.1% of the mouse colonies tested, respectively. In the present study, the positive infection rates of H. he-paticus and H. bilis were 3.17 and 0.17%, respectively. This decrease in the positive infection rates for Helicobacter species over a period of 10 years in these mouse facilities may be due to an improvement in user awareness of these agents, as well as improvements in establishing testing systems for these agents in each facility during the past 10 years.
M. pulmonis was the only category B bacterial agent (fatal pathogens) detected in mouse and rat facilities in this survey. Although the positive infection rate for M. pulmonis was relatively low (mouse facilities, 0.16%, and rat facilities, 0.57%, by serological tests), this agent should be included as a routine test item, considering its pathogenicity in mice and rats.
In term of viral agents, MNV was the most common viral agent in mouse facilities, followed by MHV. None of the viral agents tested in this survey were detected in the rat facilities. Our center formally started to test for MNV in 2009. At that time, we reported a positive MNV infection rate of 25.4% by performing PCR in mouse facilities in Japan [5] . In the present study, the positive MNV infection rate was 11.97%. Although the positive infection rate of MNV has decreased in the last 3 years, it is still relatively high. The positive MNV infection rate may decrease in the future as each facility begins to include the agent as part of their routine microbiological testing. MHV was the only Category B viral agent (fatal pathogens) to be detected in mice. These results demonstrate that there are sporadic MHV infections in mouse facilities and strongly suggest that MHV should be included as a part of a routine microbiological screening, considering its pathogenicity in mice.
it is well known that no protozoa or pinworms are detected in caesarian-derived mice and rats derived from barrier-sustained colonies. Therefore, they were categorized in our center as category e agents and tested as indicators of microbiological status of the animal colonies; the notable exceptions to this Category E classification were Giardia muris, Spironucleus muris, and Aspiculuris tetraptera, which were reported to be potential pathogens [1, 16, 18] . In the present study, no prevalence of intestinal protozoa in Category E was found in either P/C mouse or rat facilities. These data implied that strict quarantine and animal maintenance systems are common in P/C facilities.
researchers in a diagnostic laboratory in usa performed a survey of prevalent microbes for a large number of mouse and rat samples in 2003 [15] . They reported relatively high positive rates for MHV (about 2%), MPV (over 2%), epizootic diarrhea of infant mice virus (about 1%), and Helicobacter spp. (over 30%) in mice and for pneumonia virus of mice (about 1%), rat parvovirus (over 1.5%), Helicobacter spp. (about 18%), pinworms (over 10%) and Pneumocystis carinii (about 4%) in rats. In the present study, we did not detect any of these microbes except for MHV, although Helicobacter spp. and rat parvovirus were not included in our test items. These results suggest that there are geographical features related to the prevalence of microbes in mice and rats. The test items mentioned above may need to be examined in imported mice and rats from the USA during the quarantine term.
we described in this study the current microbiological status of mice and rats housed in experimental facilities in Japan based on the results of our microbiological monitoring tests performed in 2011. In summary, the prevalent microbial agents currently found in experimental facilities in Japan were mainly opportunistic pathogens, such as Staphylococcus aureus and intestinal protozoa, in both the mouse and rat facilities; additionally, MNV and H. hepaticus were prevalent in mouse facilities. Finally, the prevalence of fatal pathogens such as MHV and M. pulmonis was relatively small.
